Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 1, 1987
Projections of cancer risks attributable to future exposure to asbestosJ A MauskopfRisk Analysis : an Official Publication of the Society for Risk Analysis|December 1, 1991
Estimating the value of avoiding morbidity and mortality from foodborne illnessesJ A Mauskopf, M T FrenchThe American Journal of Cardiology|December 15, 1991
Cost-effectiveness analysis of the use of digoxin immune Fab (ovine) for treatment of digoxin toxicityJ A Mauskopf, T L WengerPharmacoeconomics|April 12, 2006
Optimal assignment of treatments to health states using a Markov decision model: an introduction to basic conceptsMohan V Bala, Josephine A MauskopfAmerican Journal of Public Health|November 1, 1992
A quality-of-life method for estimating the value of avoided morbidityM T French, J A MauskopfAmerican Journal of Preventive Medicine|June 19, 1998
Enforcement of age-appropriate immunization lawsG L Freed, V A Freeman, A MauskopfClinical Therapeutics|May 24, 2000
Savings in the cost of caring for patients with Alzheimer's disease in Canada: an analysis of treatment with rivastigmineA B Hauber, A Gnanasakthy, J A MauskopfExpert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Budget impact analysis: review of the state of the artJosephine A Mauskopf, Stephanie Earnshaw, C Daniel MullinsPharmacotherapy|September 1, 1995
Cost-consequence models for varicella-zoster virus infectionsJ E Paul, J A Mauskopf, L BellPharmacoeconomics|January 6, 2000
A pharmacoeconomic model for the treatment of influenzaJ A Mauskopf, S C Cates, A D GriffinPageof 5